GlassScriptPhysician profile
Michael Allen Hust
NPI 1568818508
$13,833.08
in general payments reported to CMS, 2019-2025
38 companies · $1,645 in 2025
The $1,645 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $504 · 2022: $6,299 · 2023: $3,845 · 2024: $1,539 · 2025: $1,645.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,356 · Travel and Lodging: $568 · Education: $106.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,355.79 |
| Travel and Lodging | $567.84 |
| Education | $106.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $6,602.13 | 2021-2025 | Turbohawk, Venaseal, Hawkone |
| Boston Scientific Corporation | $1,593.34 | 2021-2024 | Avvigo Guidance System, Lux-Dx Insertable Cardiac Monitor, Ilab Ultrasound Imaging System |
| Inari Medical, INC. | $672.16 | 2023-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Abbott Laboratories | $648.97 | 2023-2025 | Cardiomems, Xience Skypoint, Mitraclip |
| Philips North America LLC | $463.97 | 2023-2024 | (Bh4) Igt Devices Undivided |
| Biotronik INC. | $431.64 | 2022-2023 | Orsiro Mission, Pantera Leo, Pk Papyrus |
| Abiomed | $352.80 | 2023-2025 | Impella |
| Teleflex LLC | $352.33 | 2023 | Raider, Vascband, Supercross |
| Amgen INC. | $319.53 | 2023-2025 | Repatha, Repatha |
| Penumbra, INC. | $242.87 | 2023-2025 | Indigo System |
| Actelion Pharmaceuticals US, INC. | $223.82 | 2024-2025 | Uptravi, Opsumit |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $186.95 | 2023-2025 | Lifevest |
| Recor Medical INC | $172.17 | 2024 | Paradise Renal Denervation System |
| Novartis Pharmaceuticals Corporation | $168.50 | 2023-2025 | |
| Cardiovascular Systems INC. | $148.00 | 2022 |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $146.66 | 2023 | |
| Merck Sharp & Dohme LLC | $144.01 | 2023-2025 | Verquvo |
| Lexicon Pharmaceuticals, INC. | $136.72 | 2024 | Inpefa |
| Alnylam Pharmaceuticals INC. | $121.86 | 2025 | Amvuttra |
| Kestra Medical Technology Services, INC. | $96.80 | 2025 | Assure Wcd |
| Chiesi USA, INC. | $79.02 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $66.95 | 2024-2025 | Camzyos, Eliquis |
| Imperative Care, INC | $65.42 | 2025 | Prodigy Catheter, Symphony Catheter |
| Pfizer INC. | $62.19 | 2021-2025 | |
| Shockwave Medical, INC | $56.28 | 2021-2025 | |
| Angiodynamics, INC. | $33.33 | 2024-2025 | Auryon Laser System 100-120 Vac |
| Astrazeneca Pharmaceuticals LP | $31.95 | 2025 | Wainua |
| Cvrx, INC. | $25.98 | 2023 | Barostim Neo System |
| Agepha Pharma Fz LLC | $24.40 | 2025 | Lodoco |
| Glaxosmithkline, LLC. | $21.49 | 2025 | Shingrix, Arexvy |
| Janssen Pharmaceuticals, INC | $20.53 | 2024 | Xarelto |
| Cardiva Medical, INC. | $20.42 | 2022 | |
| Cleerly, INC. | $18.98 | 2025 | Cleerly Labs, Cleerly Ischemia |
| Azurity Pharmaceuticals, INC. | $18.85 | 2023 | Edarbi |
| Bard Peripheral Vascular, INC. | $17.45 | 2022 | |
| Esperion Therapeutics, INC. | $16.55 | 2023 | Nexletol |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.47 | 2025 | Jardiance |
| Vivaquant INC, Dba Rhythm Express | $13.59 | 2024 | Rhythm Express |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Hust listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.